Additionally, increased circulating levels of CD14+CD16+ monocytes have been associated with cardiovascular diseases including atherosclerosis, heart failure, myocardial infarction, and coronary artery disease (CAD) (20–25). This evidence concerns the gene CD14 and coronary artery disorder.